About this episode:

The approval of pediatric COVID vaccines during the height of the pandemic brought reassurance to many parents and pediatricians who were caring for children with severe infections and, sometimes, Multi-system Inflammatory Syndrome in Children (MISC)—a rare but extremely dangerous condition that could impact even the healthiest kids after a COVID infection. But what's the picture of pediatric COVID vaccination now? In this episode: a discussion about the risks and benefits of pediatric COVID vaccination in 2025.

Guest:

Dr. Erica Prochaska is a pediatric infectious disease physician at Johns Hopkins School of Medicine.

Host:

Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department.

Show links and related content:

• New FDA framework on Covid vaccines leaves pediatricians confused and concerned—STAT News

• A Pediatric Cardiologist on What We Know—And Don't Know—About COVID-19-Related Multi-System Inflammatory Syndrome in Children—Public Health On Call (June 2020)

Transcript information:

Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel.

Contact us:

Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.

Follow us:

• @‌PublicHealthPod on Bluesky

• @‌JohnsHopkinsSPH on Instagram

• @‌JohnsHopkinsSPH on Facebook

• @‌PublicHealthOnCall on YouTube

• Here's our RSS feed

Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.